The latest biotech news

News and Trends 7 Oct 2015

Nobel Prize in Chemistry 2015: DNA Repairing Mechanisms that Keep you Alive

DNA repair mechanisms are crucial to our existence. Without them, we would not survive because of DNA damage caused by the environment (e.g UV light damage, radiation etc.). This crucial research into discovery of three DNA repair mechanisms was led by Thomas Lindahl, Paul Modrich and Aziz Sancar who jointly received this years Nobel Prize […]

October 7, 2015 - 4 minutesmins - By Philip Hemme

News and Trends 7 Oct 2015

Sorry CRISPR, you’ll have to wait another year to win a Nobel Prize!

The first paper on CRISPR gene editing tech was only published in 2012. As a key player in the biotech revolution, CRISPR is the discovery of the century, permitting a whole new field of gene-editing for therapeutic purposes in a range of different research areas. Two of those responsible for the existence of CRISPR-Cas9, Jennifer […]

October 7, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 6 Oct 2015

Ancient Microalgae hold the Crucial gene needed for the Evolution of Plants to Land

Microalgae proves to possibly be the oldest organism exploited by the Biotech industry. Now a mass research collaboration from Wisconsin (US), Cologne (Germany), Toulouse (France) and Norwich (UK) amongst others have published in PNAS that the microalgal genes needed for bacterial and fungal symbiosis were originally present before the transition of ancient plants to land. […]

October 6, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 6 Oct 2015

Sony DADC re-purposing Blu-Ray Technology for Clinical Immunoassays

Sony Digital Audio Disc Corporation (Sony DADC) BioSciences is a DVD and Blu-ray disc manufacturer headquartered in Salzburg (Austria). A new collaboration with FIONASTICS (an immunoassay specialist) means they will use their Blu-Ray tech to develop a new nanostructure platform for fluorescent immunoassays. These will be developed for use in detection of clinical biomarkers for […]

October 6, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 6 Oct 2015

An Insider’s experience at the iGEM Giant Boston Jamboree 2015

Last week, our Guest blogger Matthieu de Costa (LinkedIn here) attended the iGEM Giant Jamboree at the Hynes Convention Center in Boston (MA). As part of the IONIS iGEM Team from the Sup’Biotech Institute for Biotechnology in Paris (France), his team came back with a Gold medal for their Bio-console video game which aims to […]

October 6, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 5 Oct 2015

Medicine Nobel Prize for Parasite Drug Discoveries which saved Billions

The Nobel Prize for Medicine and Physiology has been jointly awarded to Youyou Tu (the first ever Chinese recipient of a Nobel Prize in this category) for discovering the malarial medicine Artemisinin, and to William C. Campbell and Satoshi Ōmura, for their pioneering work in developing a major parasitic round worm disease drug, Ivermectin. These […]

October 5, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 5 Oct 2015

iGEM 2015: Europe still dominates World’s Largest Synthetic Biology Contest

The iGEM 2015 results are out! The World’s largest synthetic biology competition (24th – 28th September) held in Boston (US) has yet again shown up a great European representation in the winning teams. Divided into 3 tiers (Post-graduate, Under-graduate and High-School) winners and their projects are listed below. Originally launched by Massachusetts Institute for Technology […]

October 5, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 5 Oct 2015

€31M goes to a 15-month old Start-up tackling the leading cause of Dwarfism

TherAchon is a 15-month old start-up from the Nice area (France) which has attracted some serious US investors as of late, drawn by their pioneering protein therapy for Achondroplasia (the leading cause of Dwarfism). OrbiMed have now joined New Enterprise Associates and Versant Ventures in a €31 million series A pot for their pre-clinical candidate. […]

October 5, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 5 Oct 2015

Manfred Horst on MSD, Biosimilars, KEYTRUDA and his Company’s rich history

Manfred Horst is a Director Business Development Europe and working from an office at MSD France, the French affiliate of MSD which has its HQ in New Jersey (and is known as Merck & Co. in the US). MSD is one of the biggest pharmaceutical companies in the world with a 2014 revenue of €37.4Bn and €6.4Bn […]

October 5, 2015 - 6 minutesmins - By Julie Lellouche

News and Trends 3 Oct 2015

What Happened this Week? Abbvie abandons Galapagos, CRISPR Patent war to end and AI to exploit UK’s 100k genomes

Monday: AbbVie abandons Galapagos phase III and stock plummets 39% (and still dropping) Tuesday: Will Roche lose it’s Worldwide Leading position in Cancer treatments? Wednesday: CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9? Thursday: Artificially Intelligent ‘Betsy’ will analyse 100,000 genomes for UK Government Friday: Merck relinquishes Rare Disease license to instead […]

October 3, 2015 - 1 minutemin - By Philip Hemme

News and Trends 2 Oct 2015

Algaemy Fashion: Use of microalgae by Berlin textile design Duo

Berlin-based designers have discovered the aesthetic appeal of manipulating microalgae to produce inks for textile printing. Inspired by work in the German biotech industry, the designer duo was recently subject of a Ted talk praising their creative efforts in founding Algaemy. After visiting the Fraunhofer Institute for Interfacial Engineering and Biotechnology in Munich, Rasa Weber […]

October 2, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 2 Oct 2015

Merck relinquishes Rare Disease license to instead focus on Immuno-oncology

Merck has opted to return its Phenylketonuria (PKU) candidates Kuvan and Peg-Pal back to BioMarin from January 2016. Merck will instead focus on other R&D areas, and will receive €340M in compensation (5 times the annual sales of Kuvan) with €180M for future Peg-Pal milestones. This appears to support the back-peddling trend of major Biotechs […]

October 2, 2015 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Nobel Prize in Chemistry 2015: DNA Repairing Mechanisms that Keep you Alive

Sorry CRISPR, you’ll have to wait another year to win a Nobel Prize!

Ancient Microalgae hold the Crucial gene needed for the Evolution of Plants to Land

Sony DADC re-purposing Blu-Ray Technology for Clinical Immunoassays

An Insider’s experience at the iGEM Giant Boston Jamboree 2015

Medicine Nobel Prize for Parasite Drug Discoveries which saved Billions

iGEM 2015: Europe still dominates World’s Largest Synthetic Biology Contest

€31M goes to a 15-month old Start-up tackling the leading cause of Dwarfism

Manfred Horst on MSD, Biosimilars, KEYTRUDA and his Company’s rich history

What Happened this Week? Abbvie abandons Galapagos, CRISPR Patent war to end and AI to exploit UK’s 100k genomes

Algaemy Fashion: Use of microalgae by Berlin textile design Duo

Merck relinquishes Rare Disease license to instead focus on Immuno-oncology

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!